QVT Fund LP
10% Owner
QVT Fund LP10% Owner
QVT Fund LP insider trades: Anadys Pharmaceuticals (ANDS) stock buys and sales
10% Owner, Anadys Pharmaceuticals Last trade Oct 21, 2011 42 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
42
Open-market trades
since 2009
5
Companies
last trade 2011
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where QVT Fund LP reports to the SEC
ANDSAnadys Pharmaceuticals
10% Owner · last filing Oct 24, 2011
-$23.1M
+$9.0M
INHXInhibitex
10% Owner · last filing Sep 28, 2011
-$6.3M
+$945K
TPCGTPC Group
10% Owner · last filing Jan 4, 2011
-$2.7M
TPCPTPC Group
10% Owner · last filing Apr 8, 2010
+$2.5M
VRUSPharmasset
10% Owner · last filing Sep 24, 2009
-$19.2M
Open-market buys and sales
42 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 21, 2011 | ANDS | ↓ Sell | 5,617,618 | $3.68 | $20.7M | Through QVT Fund LP and Quintessence Fun | Oct 24, 2011 (3d) |
| Oct 17, 2011 | ANDS | ↓ Sell | 650,100 | $3.68 | $2.4M | Through QVT Fund LP and Quintessence Fun | Oct 19, 2011 (2d) |
| Sep 27, 2011 | INHX | ↓ Sell | 233,900 | $3.00 | $701K | Through QVT Fund LP and Quintessence Fun | Sep 28, 2011 (1d) |
| May 31, 2011 | INHX | ↓ Sell | 655,000 | $4.50 | $2.9M | Through QVT Fund LP and Quintessence Fun | Jun 2, 2011 (2d) |
| Apr 11, 2011 | INHX | ↓ Sell | 604,191 | $4.39 | $2.7M | Through QVT Fund LP and Quintessence Fun | Apr 11, 2011 (0d) |
| Jan 3, 2011 | ANDS | ↑ Buy | 34,209 | $1.41 | $48K | Through QVT Fund LP and Quintessence Fun | Jan 5, 2011 (2d) |
| Dec 31, 2010 | TPCG | ↓ Sell | 14,000 | $30.77 | $431K | Through QVT Fund LP and Quintessence Fun | Jan 4, 2011 (4d) |
| Dec 30, 2010 | ANDS | ↑ Buy | 317,314 | $1.45 | $461K | Through QVT Fund LP and Quintessence Fun | Jan 3, 2011 (4d) |
| Dec 28, 2010 | ANDS | ↑ Buy | 2,258,900 | $1.33 | $3.0M | Through QVT Fund LP and Quintessence Fun | Dec 29, 2010 (1d) |
| Dec 28, 2010 | TPCG | ↓ Sell | 73,600 | $30.83 | $2.3M | Through QVT Fund LP and Quintessence Fun | Dec 29, 2010 (1d) |
| Dec 23, 2010 | ANDS | ↑ Buy | 285,790 | $1.21 | $346K | Through QVT Fund LP and Quintessence Fun | Dec 27, 2010 (4d) |
| Oct 20, 2010 | ANDS | ↑ Buy | 150,000 | $1.65 | $248K | Through QVT Fund LP and Quintessence Fun | Oct 22, 2010 (2d) |
| Oct 15, 2010 | ANDS | ↑ Buy | 2,301,389 | $1.78 | $4.1M | Through QVT Fund LP and Quintessence Fun | Oct 19, 2010 (4d) |
| Sep 16, 2010 | ANDS | ↑ Buy | 8,000 | $1.78 | $14K | Through QVT Fund LP and Quintessence Fun | Sep 20, 2010 (4d) |
| Sep 10, 2010 | ANDS | ↑ Buy | 25,000 | $1.80 | $45K | Through QVT Fund LP and Quintessence Fun | Sep 14, 2010 (4d) |
| Sep 1, 2010 | ANDS | ↑ Buy | 25,000 | $1.74 | $44K | Through QVT Fund LP and Quintessence Fun | Sep 3, 2010 (2d) |
| Aug 30, 2010 | ANDS | ↑ Buy | 31,000 | $1.77 | $55K | Through QVT Fund LP and Quintessence Fun | Aug 31, 2010 (1d) |
| Aug 26, 2010 | ANDS | ↑ Buy | 33,100 | $1.72 | $57K | Through QVT Fund LP and Quintessence Fun | Aug 27, 2010 (1d) |
| Aug 24, 2010 | ANDS | ↑ Buy | 61,900 | $1.76 | $109K | Through QVT Fund LP and Quintessence Fun | Aug 25, 2010 (1d) |
| Aug 20, 2010 | ANDS | ↑ Buy | 20,000 | $1.79 | $36K | Through QVT Fund LP and Quintessence Fun | Aug 23, 2010 (3d) |
| Aug 17, 2010 | ANDS | ↑ Buy | 40,000 | $1.85 | $74K | Through QVT Fund LP and Quintessence Fun | Aug 18, 2010 (1d) |
| Aug 12, 2010 | ANDS | ↑ Buy | 32,500 | $1.94 | $63K | Through QVT Fund LP and Quintessence Fun | Aug 16, 2010 (4d) |
| Aug 3, 2010 | ANDS | ↑ Buy | 50,400 | $1.99 | $100K | Through QVT Fund LP and Quintessence Fun | Aug 5, 2010 (2d) |
| Jul 6, 2010 | ANDS | ↑ Buy | 30,000 | $1.98 | $59K | Through QVT Fund LP and Quintessence Fun | Jul 8, 2010 (2d) |
| Jul 2, 2010 | ANDS | ↑ Buy | 56,800 | $1.94 | $110K | Through QVT Fund LP and Quintessence Fun | Jul 6, 2010 (4d) |
| Apr 7, 2010 | TPCP | ↑ Buy | 194,490 | $12.75 | $2.5M | Through QVT Fund LP and Quintessence Fun | Apr 8, 2010 (1d) |
| Dec 16, 2009 | INHX | ↑ Buy | 43,000 | $0.85 | $37K | Through QVT Fund LP and Quintessence Fun | Dec 18, 2009 (2d) |
| Dec 11, 2009 | INHX | ↑ Buy | 25,000 | $0.71 | $18K | Through QVT Fund LP and Quintessence Fun | Dec 15, 2009 (4d) |
| Dec 10, 2009 | INHX | ↑ Buy | 98,000 | $0.77 | $75K | Through QVT Fund LP and Quintessence Fun | Dec 11, 2009 (1d) |
| Dec 7, 2009 | INHX | ↑ Buy | 27,000 | $0.92 | $25K | Through QVT Fund LP and Quintessence Fun | Dec 9, 2009 (2d) |
| Dec 4, 2009 | INHX | ↑ Buy | 46,500 | $0.98 | $45K | Through QVT Fund LP and Quintessence Fun | Dec 7, 2009 (3d) |
| Dec 2, 2009 | INHX | ↑ Buy | 65,000 | $0.98 | $64K | Through QVT Fund LP and Quintessence Fun | Dec 3, 2009 (1d) |
| Nov 30, 2009 | INHX | ↑ Buy | 64,300 | $0.98 | $63K | Through QVT Fund LP and Quintessence Fun | Dec 1, 2009 (1d) |
| Nov 25, 2009 | INHX | ↑ Buy | 16,592 | $0.98 | $16K | Through QVT Fund LP and Quintessence Fun | Nov 27, 2009 (2d) |
| Nov 23, 2009 | INHX | ↑ Buy | 35,700 | $0.99 | $35K | Through QVT Fund LP and Quintessence Fun | Nov 24, 2009 (1d) |
| Nov 18, 2009 | INHX | ↑ Buy | 94,500 | $0.99 | $93K | Through QVT Fund LP and Quintessence Fun | Nov 19, 2009 (1d) |
| Nov 12, 2009 | INHX | ↑ Buy | 119,000 | $1.00 | $119K | Through QVT Fund LP and Quintessence Fun | Nov 13, 2009 (1d) |
| Nov 10, 2009 | INHX | ↑ Buy | 84,000 | $0.99 | $83K | Through QVT Fund LP and Quintessence Fun | Nov 12, 2009 (2d) |
| Nov 6, 2009 | INHX | ↑ Buy | 94,000 | $0.99 | $93K | Through QVT Fund LP and Quintessence Fun | Nov 9, 2009 (3d) |
| Nov 4, 2009 | INHX | ↑ Buy | 134,000 | $1.00 | $133K | Through QVT Fund LP and Quintessence Fun | Nov 5, 2009 (1d) |
| Nov 2, 2009 | INHX | ↑ Buy | 45,036 | $0.99 | $45K | Through QVT Fund LP and Quintessence Fun | Nov 3, 2009 (1d) |
| Sep 24, 2009 | VRUS | ↓ Sell | 910,000 | $21.12 | $19.2M | Through QVT Fund LP and Quintessence Fun | Sep 24, 2009 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About QVT Fund LP's insider trades
QVT Fund LP is a 10% owner of Anadys Pharmaceuticals (ANDS). Since Sep 24, 2009, it has reported 34 open-market purchases worth $12.4M and 8 sales worth $51.3M on SEC Form 4. There have been no open-market trades in the last 12 months.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ANDS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.